We are live on ! Find out more
BCHI

GMO Beyond China ETF
BCHI

Delisted

BCHI was delisted on the 14th of August, 2026.

Back to rankings

4 hedge funds and large institutions have $1.6M invested in GMO Beyond China ETF in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

20% less funds holding

Funds holding: 5 → 4 (-1)

28.4% less ownership

Funds ownership: 43.05% → 14.65% (-28%)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

52% less capital invested

Capital invested by funds: $3.35M → $1.6M (-$1.74M)

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Lazard Asset Management
Lazard Asset Management
New York
+$531K
2
Osaic Holdings
Osaic Holdings
Arizona
+$63.7K
3
Citadel Advisors
Citadel Advisors
Florida
+$26.4K

Top Sellers

Rank Fund Capital Flow
1
CAM
Cresset Asset Management
Illinois
-$2.14M
2
Jane Street
Jane Street
New York
-$301K
3
HC
Hara Capital
Washington
-$74.9K
4
UBS Group
UBS Group
Switzerland
-$583

BCHI Hedge Fund Activity: Q2 2025 in Review

4 of the 7,617 institutional investors tracked by Wall St. Rank reported a position in GMO Beyond China ETF (BCHI) for Q2 2025, worth a combined $1.6M — down 52% from $3.35M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BCHI and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Lazard Asset Management, opening a new position worth an estimated $531K. The largest seller was Cresset Asset Management, exiting entirely with an estimated $2.14M sold.

  • 4 institutional investors held GMO Beyond China ETF (BCHI) as of Q2 2025, down from 5 in Q1 2025.
  • Funds reported $1.6M of GMO Beyond China ETF stock for Q2 2025, down 52% quarter-over-quarter.
  • 2 funds opened new GMO Beyond China ETF positions in Q2 2025 and 3 closed out, a net change of -1 holder.
  • The largest GMO Beyond China ETF buyer in Q2 2025 was Lazard Asset Management, an estimated $531K added.
  • The largest GMO Beyond China ETF seller in Q2 2025 was Cresset Asset Management, an estimated $2.14M sold.

Based on aggregated 13F filings for Q2 2025.